To: technetium who wrote (93 ) 3/6/2022 7:15:00 PM From: technetium Read Replies (2) | Respond to Well, from last week where it looked like things were only “just barely” bad, we follow with a week where it’s pretty clear that it was bad. Though some individual stocks did have a good week, only 40 out of the 189 chosen stocks were in the black for the week, (27 for YTD). Overall with losses of around 5 — 5.5% (median — avg), the contest portfolios still “outperforms" the Standard & Poor Biotech Stock index. Only two contestants: (TECHNETIUM and KMASTRA) managed to be in the black for the week.NCNA stopped their Phase III trial in biliary tract cancer “ following a pre-planned futility analysis by the study's Independent Data Monitoring Committee (IDMC).”In other words, no joy. Report Time Ranges From To Recent 2/25/22 3/5/22 YTD 12/31/21 Index Performance Symbol Recent YTD ^IXIC -2.78% -14.90% ^NBI -3.09% -17.80% ^SPSIBI -6.56% -24.95% Share Performance Recent YTD Top 5 Bottom 5 Top 5 Bottom 5 XFOR 29.032% NCNA -65.457% OPTN 67.90% PRQR -88.74% FULC 23.273% AUPH -34.852% MACK 53.20% LRMR -62.93% RETA 23.077% CLVS -25.490% LQDA 36.55% PRDS -62.74% RIGL 20.158% ADAP -23.792% RETA 21.96% JSPR -61.02% HPHA.DE 17.578% VLON -23.410% KALV 18.82% CRDF -60.90% Top 10 Portfolio Performance YTD DIEGOSAN -7.63% TECHNETIUM -10.34% HORSEINALFALFA -10.51% DEW DILIGENCE -13.20% GENEGURU -14.22% BRENDAN_49 -15.07% RKRW -18.08% STOICNORSKI -19.79% MOPGCW -20.41% A.J. MULLEN -20.59% Average and Median Portfolio Performance Avg Recent Avg YTD Median Recent Median YTD -$4,340 -24.19% BRENDAN_49 -$4,123 TOMATO -23.98% -5.51% A.J. MULLEN -5.007%
